MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 152 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,235,160 | -36.8% | 29,000 | 0.0% | 0.03% | -37.5% |
| Q2 2023 | $6,699,000 | +97.8% | 29,000 | -8.6% | 0.05% | +71.4% |
| Q1 2021 | $3,387,000 | -4.0% | 31,722 | 0.0% | 0.03% | 0.0% |
| Q4 2020 | $3,527,000 | -68.6% | 31,722 | -66.5% | 0.03% | -73.3% |
| Q3 2020 | $11,229,000 | -3.3% | 94,584 | -7.8% | 0.10% | -14.6% |
| Q2 2020 | $11,618,000 | +218.6% | 102,584 | +150.5% | 0.12% | +207.5% |
| Q1 2020 | $3,647,000 | -2.3% | 40,950 | 0.0% | 0.04% | 0.0% |
| Q4 2019 | $3,731,000 | +4.4% | 40,950 | -1.2% | 0.04% | -14.9% |
| Q3 2019 | $3,574,000 | -17.4% | 41,450 | 0.0% | 0.05% | -13.0% |
| Q2 2019 | $4,325,000 | -16.7% | 41,450 | 0.0% | 0.05% | -18.2% |
| Q1 2019 | $5,192,000 | +46.5% | 41,450 | +31.8% | 0.07% | +22.2% |
| Q4 2018 | $3,545,000 | +18.7% | 31,450 | +125.4% | 0.05% | +35.0% |
| Q3 2018 | $2,987,000 | +13.6% | 13,950 | +48.4% | 0.04% | -4.8% |
| Q2 2018 | $2,629,000 | – | 9,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |